CDER “De-Layering” Slated For Late 2003, Following OC Shuffling
This article was originally published in The Tan Sheet
Executive Summary
FDA's Center for Drug Evaluation & Research will be reorganized along with the rest of the agency's centers in mid- to late-2003
You may also be interested in...
HHS Public Affairs Centralization Plan May Ease FDA Appointment
HHS' centralization of public and legislative affairs could help ease some of the anxiety within the pharma-ceutical industry about the possible nomination of Vanderbilt University professor Alastair Wood, MD, as FDA commissioner
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands